Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
SNIP (Society on NeuroImmune Pharmacology) is a professional academic society focused on neuroimmune pharmacology. Based on the captured content, its main offerings are not online courses in the conventional sense, but rather a member community, an annual scientific conference, the official journal NIPT, a newsletter, and portals for academic jobs and related information. The 30th Scientific Conference in 2026 is planned for Annapolis, Maryland, USA, while the 29th conference in 2025 was held in Omaha.
Its educational value is centered on high-level academic conferences and interdisciplinary discussion. The text notes that its membership consists of clinical and preclinical translational scientists, and that the conference features a broad range of thematic presentations, as well as poster and oral presentation sessions for early-career researchers. The invited speakers have strong backgrounds, including Nora Volkow from NIDA/NIH, Avindra Nath from NINDS/NIH, Amy Janes from NIDA IRP, and professors from institutions such as the University of North Dakota and the University of Washington. The society also runs the open-access journal Neuroimmune Pharmacology and Therapeutics (NIPT), with Howard Gendelman as Editor-in-Chief.
The captured text does not disclose membership fees, conference registration fees, publication charges, or payment methods. It also does not indicate whether completion certificates, continuing education credits, or professional certifications are offered. Therefore, if assessed as a “course product,” its pricing transparency and certification information are limited.
Its strength lies in its highly specialized focus, making it suitable for people already working in neuroscience, immunology, pharmacology, or research related to addiction and neurological diseases. The conference speakers and society network carry clear academic value, and the society emphasizes support for trainees, having offered travel awards in the past. The limitations are also clear: it is not a structured course platform, and there is no defined learning path, class schedule, or beginner-oriented instructional design. Conferences are primarily held in person in the United States, so learners from China would need to account for travel, visa, and time zone/geographic costs.
It is better suited to graduate students, postdocs, PIs, clinical translational researchers, and professionals who want to submit papers or build collaborations. It is not suitable for complete beginners or those seeking a professional certificate. Access from mainland China is not specified in the text, so it should be considered unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on hashzeta.com official site.
hashzeta.com is an United States Education provider. TG4G tracks its product information, an overall rating of 4.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach hashzeta.com directly.